切换导航
News
All Journals
All Articles
Subscribe
Sign up for updates about the journal.
Subscribe
Sign in
Register
Exploration of Targeted Anti-tumor Therapy
切换导航
5.4
CiteScore
PubMed
Indexed
Submit Manuscript
About
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
About
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
Search
All Journals
Exploration of Medicine
Exploration of Targeted Anti-tumor Therapy
Exploration of Immunology
Exploration of Neuroprotective Therapy
Exploration of Digestive Diseases
Exploration of Neuroscience
Exploration of Musculoskeletal Diseases
Exploration of Drug Science
Exploration of Asthma & Allergy
Exploration of Foods and Foodomics
Exploration of Digital Health Technologies
Exploration of Cardiology
Exploration of BioMat-X
Exploration of Endocrine and Metabolic Diseases
All
Article Title
Abstract
Author
Keywords
Institution
Home
/
Exploration of Targeted Anti-tumor Therapy
/
Articles
Journal Information
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Special lssues
Guest Editor Guidelines
Author Instructions
Editorial Process
Article Processing Charges
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
Download Journal Flyer
413
results in
Exploration of Targeted Anti-tumor Therapy
Latest
Latest
Most Viewed
Most Downloaded
Most Cited
Sort by :
Refine Search by
Article Type
Review (239)
Original Article (89)
Case Report (19)
Perspective (19)
Systematic Review (14)
Commentary (7)
Meta-Analysis (6)
Mini Review (6)
Editorial (4)
Letter to the Editor (3)
Short Communication (3)
Protocol (1)
Correction (1)
Retraction (1)
Meeting Abstracts (1)
Consensus Statement (0)
Show more
Hide more
Apply
Year
2026 (58)
2025 (72)
2024 (83)
2023 (82)
2022 (52)
2021 (37)
2020 (29)
Apply
Volume
Vol. 7 (2026)
Vol. 6 (2025)
Vol. 5 (2024)
Issue 6
Issue 5
Issue 4
Issue 3
Issue 2
Issue 1
Vol. 4 (2023)
Issue 6
Issue 5
Issue 4
Issue 3
Issue 2
Issue 1
Vol. 3 (2022)
Issue 6
Issue 5
Issue 4
Issue 3
Issue 2
Issue 1
Vol. 2 (2021)
Issue 6
Issue 5
Issue 4
Issue 3
Issue 2
Issue 1
Vol. 1 (2020)
Issue 6
Issue 5
Issue 4
Issue 3
Issue 2
Issue 1
413
results in
Exploration of Targeted Anti-tumor Therapy
Latest
Latest
Most Viewed
Most Downloaded
Most Cited
Sort by :
Open Access
Original Article
Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing
tumour protein 53
gene status
Ali JN Duabil ... George DD Jones
Published: December 21, 2023 Explor Target Antitumor Ther. 2023;4:1210–1226
DOI:
https://doi.org/10.37349/etat.2023.00193
Full Text
PDF
5544
36
1
Open Access
Original Article
Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer
Vignesh Sivaganesh, Bela Peethambaran
Published: December 20, 2023 Explor Target Antitumor Ther. 2023;4:1188–1209
DOI:
https://doi.org/10.37349/etat.2023.00192
Full Text
PDF
5020
41
10
Open Access
Case Report
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
Sviatoslav Chekhun ... Maria Saigí
Published: December 13, 2023 Explor Target Antitumor Ther. 2023;4:1182–1187
DOI:
https://doi.org/10.37349/etat.2023.00191
Full Text
PDF
4277
21
0
Open Access
Review
Targeting cancer stem cell plasticity in triple-negative breast cancer
Zhengwang Guo, Shuyan Han
Published: December 11, 2023 Explor Target Antitumor Ther. 2023;4:1165–1181
DOI:
https://doi.org/10.37349/etat.2023.00190
This article belongs to the special issue
Innovative Strategies to Target Triple-negative Breast Cancer
Full Text
PDF
8136
68
15
Open Access
Case Report
Unexpected “Lazarus response” to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer
Alexey V. Emshanov ... Evgeny N. Imyanitov
Published: December 06, 2023 Explor Target Antitumor Ther. 2023;4:1157–1164
DOI:
https://doi.org/10.37349/etat.2023.00189
Full Text
PDF
3712
25
1
Open Access
Original Article
Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy
Witida Laopajon ... Watchara Kasinrerk
Published: December 06, 2023 Explor Target Antitumor Ther. 2023;4:1145–1156
DOI:
https://doi.org/10.37349/etat.2023.00188
This article belongs to the special issue
Novel Strategies and Targets for Immunotherapy of Cancer
Full Text
PDF
5826
38
0
Open Access
Meta-Analysis
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis
Marco Filetti ... Gennaro Daniele
Published: December 01, 2023 Explor Target Antitumor Ther. 2023;4:1136–1144
DOI:
https://doi.org/10.37349/etat.2023.00187
Full Text
PDF
4280
74
3
Open Access
Commentary
A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present?
Dimitrios Bouzianas, Stella Bouziana
Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1128–1135
DOI:
https://doi.org/10.37349/etat.2023.00186
This article belongs to the special issue
Novel Strategies and Targets for Immunotherapy of Cancer
Full Text
PDF
6988
25
2
Open Access
Perspective
Cholesterol esterification and p53-mediated tumor suppression
Youjun Li ... Edward V. Prochownik
Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1122–1127
DOI:
https://doi.org/10.37349/etat.2023.00185
This article belongs to the special issue
Therapeutic Targeting of the Tumor Microenvironment
Full Text
PDF
5544
33
3
Open Access
Original Article
Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression
Levi Arnold ... Sufi Mary Thomas
Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1104–1121
DOI:
https://doi.org/10.37349/etat.2023.00184
This article belongs to the special issue
Therapeutic Targeting of the Tumor Microenvironment
Full Text
PDF
5170
94
3
Open Access
Systematic Review
Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
Veronica Agostinelli ... Rossana Berardi
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1095–1103
DOI:
https://doi.org/10.37349/etat.2023.00183
This article belongs to the special issue
COVID-19 and Cancer
Full Text
PDF
3981
19
0
Open Access
Review
Coronavirus disease 2019 and lung cancer: where are we?
Abrahams Ocanto ... Felipe Couñago
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1082–1094
DOI:
https://doi.org/10.37349/etat.2023.00182
This article belongs to the special issue
COVID-19 and Cancer
Full Text
PDF
4851
18
2
Open Access
Review
Overcoming phenotypic switching: targeting protein-protein interactions in cancer
Christos Ladias ... Nikolaos A. Papanikolaou
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1071–1081
DOI:
https://doi.org/10.37349/etat.2023.00181
This article belongs to the special issue
Off-Label Drugs and -Omics Data in Cancer Treatment
Full Text
PDF
7064
40
1
Open Access
Original Article
Effect of vitamin D supplementation on inflammatory markers and total antioxidant capacity in breast cancer women using a machine learning technique
Marzieh Tahmasebi ... Amir Jamshidnezhad
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1059–1070
DOI:
https://doi.org/10.37349/etat.2023.00180
Full Text
PDF
4313
29
2
Open Access
Systematic Review
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review
Afrooz Mazidimoradi ... Hamid Salehiniya
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1039–1058
DOI:
https://doi.org/10.37349/etat.2023.00179
This article belongs to the special issue
COVID-19 and Cancer
Full Text
PDF
4109
16
2
Open Access
Review
Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer
Gerhard Hamilton ... Barbara Rath
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1027–1038
DOI:
https://doi.org/10.37349/etat.2023.00178
This article belongs to the special issue
Integrated Approaches for Non-Small-Cell Lung Cancer
Full Text
PDF
6970
24
3
Open Access
Review
A review on
in silico
virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors
Babak Sokouti
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:994–1026
DOI:
https://doi.org/10.37349/etat.2023.00177
Full Text
PDF
6570
55
2
Open Access
Review
Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses
George Anderson
Published: October 25, 2023 Explor Target Antitumor Ther. 2023;4:962–993
DOI:
https://doi.org/10.37349/etat.2023.00176
This article belongs to the special issue
Novel Insights into Immunotherapy Targeting Tumor Microenvironment in Cancer
Full Text
PDF
9152
48
20
Open Access
Review
Biomarkers in renal cell carcinoma and their targeted therapies: a review
Shruti Gupta, Shamsher Singh Kanwar
Published: October 25, 2023 Explor Target Antitumor Ther. 2023;4:941–961
DOI:
https://doi.org/10.37349/etat.2023.00175
This article belongs to the special issue
Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
Full Text
PDF
10045
53
17
Open Access
Systematic Review
Current role of artificial intelligence in head and neck cancer surgery: a systematic review of literature
Antonella Loperfido ... Gianluca Bellocchi
Published: October 24, 2023 Explor Target Antitumor Ther. 2023;4:933–940
DOI:
https://doi.org/10.37349/etat.2023.00174
This article belongs to the special issue
Artificial Intelligence for Precision Oncology
Full Text
PDF
6299
63
19
Previous
1
...
10
11
12
13
14
...
21
Next
To
Go
Journal Information
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Special lssues
Guest Editor Guidelines
Author Instructions
Editorial Process
Article Processing Charges
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
Download Journal Flyer